GSK Plc
US ˙ OTCM
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityGLAXD / GSK Plc
InstitutionOptiver Holding B.V.
Optiver Holding B.V. ownership in GLAXD / GSK Plc

Optiver Holding B.V. has a history of taking positions in derivatives of the underlying security (GLAXD) in the form of stock options. The firm currently holds call options representing 182,600 of underlying shares valued at $10,077,694 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GLAXD / GSK Plc Historical Put/Call Ratio
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-06-02 2026-03-31 13F/A GSK SPONSORED ADR Call 182,600 -14.71 10,078 -4.02 n/a n/a n/a
2026-05-15 2026-03-31 13F GSK SPONSORED ADR Call 182,600 10,078 n/a n/a n/a
2026-02-17 2025-12-31 13F GSK SPONSORED ADR Call 214,100 1.13 10,499 14.92 n/a n/a n/a
2025-11-10 2025-09-30 13F GSK SPONSORED ADR Call 211,700 -11.50 9,137 -0.53 n/a n/a n/a
2025-08-14 2025-06-30 13F GSK SPONSORED ADR Call 239,200 -27.16 9,185 -27.80 n/a n/a n/a
2025-05-15 2025-03-31 13F GSK SPONSORED ADR Call 328,400 -32.34 12,722 -22.50 n/a n/a n/a
2025-02-14 2024-12-31 13F GSK SPONSORED ADR Call 485,400 13.09 16,416 -6.43 n/a n/a n/a
2024-11-14 2024-09-30 13F GSK SPONSORED ADR Call 429,200 -19.69 17,546 -14.72 n/a n/a n/a
2024-08-14 2024-06-30 13F GSK SPONSORED ADR Call 534,400 -36.15 20,574 -43.01 n/a n/a n/a
2024-05-09 2024-03-31 13F GSK SPONSORED ADR Call 836,900 -9.74 36,104 5.45 n/a n/a n/a
2024-02-13 2023-12-31 13F GSK SPONSORED ADR Call 927,200 1.78 34,237 3.24 n/a n/a n/a
2023-11-13 2023-09-30 13F GSK SPONSORED ADR Call 911,000 -8.05 33,162 -5.16 n/a n/a n/a
2023-08-10 2023-06-30 13F GSK SPONSORED ADR Call 990,800 1.29 34,966 1.40 n/a n/a n/a
2023-05-11 2023-03-31 13F GSK SPONSORED ADR Call 978,200 76.86 34,484 79.23 n/a n/a n/a
2023-02-10 2022-12-31 13F GSK SPONSORED ADR Call 553,100 27.50 19,240 52.76 n/a n/a n/a
2022-11-14 2022-09-30 13F GSK SPONSORED ADR Call 433,800 12,595 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.